Through a comprehensive analysis of the remaining rare SVs, we identified three SVs of interest that potentially overlap novel candidate genes of CHD/HTX in three patients, including CEP164 and SMARCA2. This evidence concerns the gene ZIC3 and coronary artery disorder.